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Abstract The two stimulatory G protein K subunits, GKs and
GKolf, activate adenylyl cyclase in a similar way. We examined
whether type 5 adenylyl cyclase knockout, the major striatal
isoform, can di¡erentially and/or developmentally change the
expression of these G proteins in the striatum. GKs and GKolf
expressions at birth were una¡ected in knockouts, which, how-
ever, demonstrated a blunted developmental increase in GKolf,
but not GKs. Adenylyl cyclase activity was una¡ected at birth,
but subsequently became lower in knockouts. These ¢ndings
suggest that type 5 adenylyl cyclase does not contribute to
striatal cAMP signaling at birth. However, it may play an
important role in developmental changes in the expression of
GKolf, but not GKs.
( 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Adenylyl cyclase (AC) is a membrane-bound enzyme that
catalyzes the conversion of ATP to cAMP upon activation by
G proteins, leading to a cascade of phosphorylation reactions
within the cell [1,2]. There are at least nine isoforms of AC
within the family, which show distinct biochemical properties
and tissue distribution. Heterotrimeric G proteins consist of
multiple subtypes, which are subdivided into at least four
subfamilies. The stimulatory G protein subfamily is charac-
terized by the presence of two G protein K subunits, GKs and
GKolf, both of which can directly activate AC regardless of its
isoform, at least in vitro. GKs, a ubiquitous subtype, and
GKolf, a major olfactory subtype, share more than 80% ami-
no acid identity, and it is thus believed that both have similar
biochemical properties in vitro [3,4]. It remains poorly under-
stood, however, whether the expression of both G protein
species (GKs and GKolf) is similarly regulated by cAMP sig-
nal in intact animals.
Several studies have demonstrated that the adult striatum
expresses GKolf and type 5 AC (AC5) as the dominant sub-
type [5^7]. We were interested in whether changes at the level
of AC can regulate the expression of G proteins, and if so,
whether either or both AC and G proteins are developmen-
tally regulated in the striatum. A very recent study from our
laboratory has demonstrated that the expression of GKs-like
protein in the striatum was decreased in mice with a disrupted
AC5 gene (AC5KO) without changes in the expression of
other G protein species such as Gi [8]. AC5KO mice exhibited
motor dysfunction that mimicked Parkinson’s disease; this
dysfunction was apparent in adults, but not in younger
mice. In this regard, mice with disrupted D1 or A2a receptor
genes demonstrated that the expression of GKolf, but not
GKs, was a¡ected [6], suggesting that GKolf and GKs are
di¡erentially regulated in vivo, although both have similar
biochemical properties in vitro [9].
2. Materials and methods
2.1. Generation of knockout mice
The AC5 gene was disrupted by the homologous recombination
technique in the exon with the ¢rst translation initiation site as de-
scribed previously [8,10]. All mice were 129/SvJ-C57BL/6 mixed-back-
ground littermates from F1 heterozygote crosses. This study was ap-
proved by the Animal Care and Use Committee at both Yokohama
City University School of Medicine and New Jersey Medical School.
2.2. Sample preparation for immunoblotting and AC assays
Mice were killed at postnatal day (P) 0, 7, 14, or 21. The brains
were rapidly removed and the striatal tissues were dissected in ice-cold
phosphate-bu¡ered saline under a microscope, quickly frozen in liquid
nitrogen, and stored at 380‡C until use. After thawing, the tissues
were homogenized in a bu¡er containing 50 mM Tris^HCl (pH 8.0),
1 mMEGTA, 1 mMEDTA, 1 mM dithiothreitol, 200 mM sucrose, and
a protease inhibitor mixture containing 20 Wg/ml 1-chloro-3-tosylami-
do-7-amino-L-2-heptanone, 10 Wg/ml leupeptin, 0.1 mM phenylmeth-
ylsulfonyl £uoride, 50 U/ml egg white trypsin inhibitor, and 2 Wg/ml
aprotinin (bu¡er A) by using a glass homogenizer on ice. The homo-
genates were centrifuged at 500Ug for 10 min at 4‡C. The super-
natants were retained and further centrifuged at 100 000Ug for 30
min at 4‡C. Crude membrane preparations were made by resuspend-
ing the pellet in the same bu¡er without EGTA (bu¡er B).
2.3. Immunoblot analysis
Western blotting for various G proteins and AC isoforms was con-
ducted using the membrane preparation of striatal tissues at each
developmental stage. Immunodetection was performed using the
Chemiluminescent system (Amersham Pharmacia Biotech, Piscat-
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away, NJ, USA). Antibodies to the above molecules were obtained
from Upstate Biotechnology (Lake Placid, NY, USA), NEN Life
Science Products (Boston, MA, USA) and Santa Cruz Biotechnology
(Santa Cruz, CA, USA). The speci¢c antibodies for GKs (004/49SP)
and GKolf (186/49SP) were developed by a member of the present
team as previously described [6,11].
2.4. AC assay
AC assays were conducted in a reaction mixture containing 80 mM
Tris malate (pH 7.4), 0.4 mM EGTA, 2 mM MgSO4, 1 mM 3-iso-
butylmethylxanthine, 5 mM phosphocreatine, 50 U/ml creatine phos-
phokinase, 0.02% ascorbic acid, 0.1 mM ATP (2^3U106 cpm of
[32P]ATP), and 40 Wg of membrane protein in a ¢nal assay volume
of 200 Wl [12]. Assays were conducted at 30‡C for 20 min. The reac-
tion was terminated by the addition of 100 Wl of 50 mM Tris^HCl
containing 45 mM ATP and 2% sodium dodecyl sulfate. AC activity
was linear within the incubation time up to 30 min.
2.5. Statistics
All data are given as meansRS.E.M. Statistical signi¢cance was
determined using either Student’s t-test or analysis of variance.
P6 0.05 was taken as a minimal level of signi¢cance.
3. Results
3.1. Changes in G proteins
A commercially available GKs antibody detected both 52-
and 45-kDa bands in all three tissues (cortex, striatum, and
heart) (Fig. 1A). The intensity of these two bands was similar
between AC5KO and WT in the cortex and heart, but a
di¡erence was observed in the striatum. It should be noted
that AC5 is abundantly expressed in both the striatum and
heart, but the expression of G protein was di¡erent only in the
striatum. In the striatum of AC5KO, the expression of the 52-
kDa band remained unchanged from that in WT, but the
expression of the 45-kDa band was decreased; this was in
agreement with our previous ¢ndings [8]. The commercially
available GKs antibody may cross-hybridize to GKolf because
of their high amino acid sequence similarity, and thus we were
interested in examining the expression of GKolf in the stria-
tum of AC5KO. We were also interested in developmental
changes in G protein expression in AC5KO because they
may be related to the development of motor dysfunction in
AC5KO.
We examined the expression of GKolf and GKs using spe-
ci¢c antibodies that can di¡erentially detect each G protein
species [6,11] (Fig. 1B,C). We found that the expression of
GKs, both the short and long forms, was similar between
AC5KO and WT in all tissues (Fig. 1B). In contrast, the
expression of GKolf, which is most abundant in the striatum
among the three tissues, was decreased in AC5KO. These
¢ndings suggested that AC5KO mice underwent a speci¢c
decrease in the striatal expression of GKolf, but not GKs.
We then examined the developmental changes of these G
proteins in the striatum. It should be noted that motor dys-
function in AC5KO was apparent in adults, but not in early
developmental stages [8], suggesting that the defect in striatal
cAMP signaling occurs only in adults. In both WT and
AC5KO, the expression of the long form of GKs decreased
and that of the short form of GKs increased with development
(P0 through P21), which was in agreement with previous re-
ports [13,14] (Fig. 2). Importantly, the same changes occurred
in AC5KO and WT. Developmental changes in the expression
of GKolf were similar to those of the short form of GKs in
WT; GKolf levels increased dramatically with development,
reaching a plateau after P14 (Fig. 3). This developmental in-
crease, however, was blunted in AC5KO; the expression of
GKolf was similar until P7, but signi¢cantly lower in AC5KO
than in WT after P14.
These ¢ndings suggested that the amount of G proteins
(GKolf and both forms of GKs) was similar at birth, but the
amount of GKolf di¡ered thereafter in AC5KO. We also ex-
amined changes in other G protein species, GL and GKi, but
found no di¡erence between AC5KO and WT (data not
shown). Because GKolf is the dominant stimulatory GK pro-
tein in the striatum, the impact of blunted developmental in-
crease on cAMP signaling in the striatum of AC5KO is likely
Fig. 1. Immunodetection of GKolf and GKs in the cortex, striatum, and heart. A commercial GKs antibody (A), a GKs-speci¢c antibody (004/
49SP) (B), and a GKolf-speci¢c antibody (186/49SP) were compared. Detection of GKolf (Golf) and the short (Gs short) and long forms (Gs
long) of GKs is shown in wild type (WT) and AC5KO (KO) among the three tissues (10 Wg from cortex, striatum, and heart).
Fig. 2. Developmental changes in the expression of GKs. Striatal
membranes were prepared from wild type (open bars, WT) and
AC5KO (closed bars, KO) at P0, P7, P14, and P21, followed by im-
munoblotting for GKs. Representative photos of immunoblotting,
using 10 Wg of tissue protein per lane, are also shown (insets). Val-
ues are shown as a percentage of WT at P0. MeansRS.E.M. are
shown. *P6 0.05 relative to P0, n=5.
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to be signi¢cant. Further, it is tempting to speculate that
GKolf and GKs, both of which activate AC in a similar way
in vitro, may be regulated di¡erentially in the striatum.
3.2. Changes in AC
The above ¢ndings suggested a speci¢c defect in the devel-
opmental increase of GKolf in AC5KO. We thus examined
whether similar changes occurred at the level of AC during
development. AC activity was measured using striatal mem-
brane preparations at di¡erent developmental stages (Fig. 4).
Total AC activities, both basal and stimulated (NaF and for-
skolin), were markedly increased with development in WT. In
AC5KO, however, total AC activities were increased, but
reached a plateau from P7 to P14, which is reminiscent of
changes in GKolf (Fig. 3). AC activity at birth was not di¡er-
ent between AC5KO and WT. The di¡erence in AC activity
between WT and AC5KO observed at P14 and P21 was great-
er upon forskolin stimulation than in the presence of NaF,
suggesting changes in the composition of AC isoforms.
We thus examined whether changes in the expression of
speci¢c AC isoforms played a role in such alterations in AC
activity. Among AC isoforms, AC3 and AC5 were readily
detected in the striatum by the use of commercially available
antibodies; however, other AC antibodies, including AC1 or
AC2, did not readily detect signals in the striatum (data not
shown). In WT animals, we found that the expression of AC5
was hardly detectable at birth, but increased with develop-
ment, reaching a plateau after P14 (Fig. 5). AC3 expression
was similar to AC5, increasing with development and reaching
a plateau after P14. Importantly, there was no di¡erence in
the expression of AC3 between AC5KO and WT, suggesting
that there is no compensatory increase of AC3 in AC5KO.
The lack of increase in AC activity in AC5KO after P7 most
likely re£ected a lack of AC5 expression in the striatum while
the expression of other AC isoforms, such as AC3, appeared
una¡ected in AC5KO. More importantly, AC5 was not read-
Fig. 3. Developmental changes in the expression of GKolf. Striatal
membranes were prepared from wild type (open bars, WT) and
AC5KO (closed bars, KO) at P0, P7, P14, and P21, followed by im-
munoblotting for GKolf (Golf). Representative photos of immuno-
blotting, using 10 Wg of protein per lane, are also shown (insets).
Values are shown as a percentage of WT at P0. MeansRS.E.M. are
shown. *P6 0.05 relative to P0, #P6 0.05 relative to WT, n=5.
Fig. 4. Developmental changes in AC activity. Striatal membranes
were prepared from wild type (open bars, WT) and AC5KO (closed
bars, KO) at P0, P7, P14, and P21, followed by AC assays. AC as-
says were conducted in the absence (Basal) or presence of 10 mM
NaF or 100 WM forskolin (Fsk). Values are shown as a percentage
of WT at P0. MeansRS.E.M. are shown. *P6 0.05 relative to P0,
#P6 0.05 relative to WT, n=4.
Fig. 5. Developmental changes in the expression of AC3 and AC5. Striatal membranes were prepared from wild type (open bars, WT) and
AC5KO (closed bars, KO) at P0, P7, P14, and P21, followed by immunoblotting for AC3 and AC5. Representative photos of immunoblotting,
using 25 Wg of protein per lane, are also shown (insets). Values are shown as a percentage of WT at P0 (AC3) or P7 (AC5). MeansRS.E.M.
are shown. *P6 0.05 relative to P0, #P6 0.05 relative to WT, n=4.
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ily detectable and AC activity was similar at birth between
AC5KO and WT, suggesting that AC5 does not contribute to
striatal AC activity at birth, even though it is the major AC
isoform in the adult striatum.
The above ¢ndings suggested that there was a defect in
developmental increase of GKolf in AC5KO. The magnitude
of di¡erence in cAMP signaling, as determined by AC activ-
ity, the amount of G proteins and AC isoforms, was insignif-
icant at birth but increased signi¢cantly thereafter. This may
explain, at least partially, why the apparent motor dysfunc-
tion in AC5KO was not obvious at birth. Our ¢ndings also
suggest that the expression of GKolf is a¡ected developmen-
tally by the activity of AC. It is interesting to note that the
expression of GKs, which can interact with AC5, was un-
changed in AC5KO. Similarly, the expression of AC3, which
can interact with GKolf, was not altered in AC5KO either.
Because both AC3 and GKolf are originally found and dom-
inantly expressed in the olfactory epithelium, no changes were
expected in GKolf expression without changes in AC3 expres-
sion. Perhaps GKolf interacts more closely with AC5 than
with AC3 in the striatum. This interaction may play an im-
portant role in the regulation of dopaminergic signaling in the
basal ganglia [15]. In support of this hypothesis, in GKolf
knockout mice, the locomotor responses to cocaine or am-
phetamine, which also require dopaminergic signaling and
AC [16], were attenuated [15]. To examine the molecular
mechanisms underlying the changes of GKolf, we conducted
a series of Northern blot analyses. However, we found no
changes in the mRNA expression of GKolf between AC5KO
and WT (data not shown), suggesting that the change in G
protein levels occurred post-transcriptionally.
Our results also suggested that AC5 is the dominant AC
isoform in the striatum in adults, but not at birth because
membrane AC activity was similar between AC5KO and
WT. AC5 expression is increased with development in both
the striatum and heart [17], where AC5 is the dominant iso-
form. More importantly, the disruption of AC5 did not alter
this developmental increase of another AC isoform, AC3,
suggesting the absence of compensatory changes in other
AC isoforms. It is tempting to speculate that GKolf levels
were regulated not only by the usage of GKolf-stimulating
receptors [6], but also by the presence of its e¡ector AC iso-
form in the striatum.
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